Back to Results
First PageMeta Content
Cardiovascular physiology / Aging-associated diseases / Heart diseases / Omecamtiv Mecarbil / Cardiomyopathy / Heart failure / Cardiac output / Ejection fraction / Echocardiography / Circulatory system / Anatomy / Medicine


RATIONALE AND DESIGN FOR A PHASE II STUDY EVALUATING THE EFFECT OF THE CARDIAC MYOSIN ACTIVATOR, CK, ON CARDIAC FUNCTION, HEMODYNAMICS, AND MYOCARDIAL OXYGEN CONSUMPTION IN PATIENTS WITH HEART FAILURE J D Parker1
Add to Reading List

Document Date: 2008-09-23 09:34:32


Open Document

File Size: 1,18 MB

Share Result on Facebook

City

Toronto / Salt Lake City / Baltimore / Durham / /

Company

Saikali KG / /

Country

United States / Canada / /

Event

FDA Phase / /

Facility

Stable Heart Failure3 Pharmacokinetic/Pharmacodynamic Relationship Open-label / F I Malik4 Mt. Sinai Hospital / Clinical Research Institute / /

MedicalCondition

acute coronary syndrome / heart failure / traditional hemodynamic heart failure / stable heart failure / greater heart failure / stroke / /

MedicalTreatment

heart catheterization / cardiac catheterization / catheter / /

Organization

5Duke Clinical Research Institute / Malik4 Mt. Sinai Hospital / /

Product

CK-1827452 / /

ProvinceOrState

Maryland / Utah / North Carolina / California / Ontario / /

SocialTag